AI-generated from publicly available materials.XRlabs, a London-based company focused on integrating AI into surgical practices, has successfully secured €7.48 million ($8.4 million) in Seed funding to enhance its innovative offerings.
Led by Playground Global, a venture firm specializing in DeepTech, the funding round also saw participation from Eka Ventures. Notably, Omar Ishrak, former Chairman and CEO of Medtronic, has joined XRlabs as Chair of its Board of Directors. The company, founded by neurosurgeon Dr. Ali Haddad in 2024, aims to revolutionize the surgical landscape by developing software that serves as an AI layer over existing hospital systems.
XRlabs' platform leverages advanced technologies like computer vision and deep learning to synthesize real-time surgical data, enhancing the decision-making process during operations. Its two primary products, XRlabs SIM and SurgicalOS, work in tandem to create a comprehensive digital model of surgical procedures, thereby improving pre-operative planning and intraoperative execution. The company has already implemented its technology in over 100 surgical cases across three continents.
With this funding, XRlabs plans to expand its engineering and clinical teams, navigate regulatory pathways in multiple regions, and bolster its clinical evidence base. The company is also set to enhance its AI capabilities through a partnership with the UK AI Research Resource, positioning itself as a key player in the future of surgical intelligence.